Dosing & Uses
Multiple Sclerosis
Pending FDA approval for treatment of adult patients with relapsing multiple sclerosis (MS)
Next:
Pharmacology
Mechanism of Action
Selective sphingosine-1-phosphate receptor 1 (S1P1) immunomodulator
Binds with high affinity to S1P receptors; blocks lymphocyte egress from lymph nodes
Mechanism by which ponesimod exerts therapeutic effects in MS is unknown, but may involve reduction of lymphocyte migration into the central nervous system and damage to myelin
Previous
Next:
Images
Previous
Next:
Patient Handout
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
